Table 1.
Smokers (N=48) | Non-smokers (N=25) | |||
---|---|---|---|---|
Bupropion (N=29) |
Placebo (N=19) |
Bupropion (N=7) |
Placebo (N=18) |
|
Age, mean | 35 | 33 | 34 | 36 |
Gender, % (N) | ||||
Male | 66% | 63% | 43% | 72% |
Female | 34% | 37% | 57% | 28% |
Ethnicity, % (N) | ||||
White | 59% | 63% | 43% | 50% |
Hispanic | 34% | 31% | 57% | 39% |
Other | 3% | 5% | 0% | 11% |
Educational, mean years | 12.8 | 12.5 | 13.7 | 13.0 |
Days of MA use in past month, mean | 13a | 15 | 23a | 17 |
Cigarettes per day at baseline | 11.4 | 11.7 | - | - |
| ||||
Treatment Outcomes | ||||
| ||||
Days retained, mean | 52 | 49 | 55 | 53 |
End-of-Treatment Abstinence | 17% | 16% | 14% | 17% |
Treatment Effectiveness Score (mean negative Urine Drug Screens) |
4.6 | 4.8 | 4.9 | 4.6 |
Group difference significant (p<.05)